Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents
Abstract Background It was our impression that safety outcome trials were getting more frequent, raising ethical issues mainly related to patient autonomy. We and others had also proposed this autonomy would be best served if wording of the informed consents would be in the public domain. Methods In...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-025-08732-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585451198742528 |
|---|---|
| author | Sinem Nihal Esatoglu Ayse Ozdede Yesim Ozguler Koray Tascilar Hasan Yazici |
| author_facet | Sinem Nihal Esatoglu Ayse Ozdede Yesim Ozguler Koray Tascilar Hasan Yazici |
| author_sort | Sinem Nihal Esatoglu |
| collection | DOAJ |
| description | Abstract Background It was our impression that safety outcome trials were getting more frequent, raising ethical issues mainly related to patient autonomy. We and others had also proposed this autonomy would be best served if wording of the informed consents would be in the public domain. Methods Initially two observers and an arbiter tabulated the main aims of randomized controlled trials (RCTs) published in 1990–1991 vs. 2019–2020 as efficacy, safety, or undecided in four mainline medical journals, from the websites. A pragmatic design as well as other salient features was also tabulated. After noting too many trials were categorized as undecided, two additional independent observers and the arbiter did a reassessment. Results In our reassessment of 889 RCTs, 309 in earlier and 580 in the later time period, 828 (93%) were categorized as efficacy and 47 (5%) as a safety trial. We were undecided in 14 (2%) trials. The proportion of safety outcome trials between the two time periods were similar [14/309 (5%) vs. 33/580 (6%)] while RCTs of any category conducted in the critical care settings notably increased in time [12/309 (4%) vs. 52/580 (9%) OR 2.4; 1.3–4.6]. Death was a primary outcome measure in 0/14 among the earlier and 16/33 (49%) among the later safety outcome trials. Stroke in 9 and myocardial infarction in 8 safety outcome trials were additional primary outcome measures in the same group. There were 2 pragmatic trials in the earlier and 93 in the later period. Conclusion Although we did not observe a differential increase among the safety outcome trials of all categories, those in critical care settings had significantly increased in time. So did the safety outcome trials with primary outcome measures like death, myocardial infarction, and stroke as well as randomized controlled trials with a pragmatic design. These raise the issue of autonomy related to how clearly the sought-after safety through designing empirical studies primarily to quantitate harm had been worded to the trial participants in plain language. We maintain this issue cannot be adequately addressed unless the informed consent forms, especially for safety outcome trials, are in the public domain. |
| format | Article |
| id | doaj-art-bf392f6435714cfa81844cdffd0de7d8 |
| institution | Kabale University |
| issn | 1745-6215 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj-art-bf392f6435714cfa81844cdffd0de7d82025-01-26T12:51:10ZengBMCTrials1745-62152025-01-0126111010.1186/s13063-025-08732-xSafety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consentsSinem Nihal Esatoglu0Ayse Ozdede1Yesim Ozguler2Koray Tascilar3Hasan Yazici4Division of Rheumatology, Department of Medicine, Cerrahpasa Medical School, Istanbul University-CerrahpasaDivision of Rheumatology, Department of Medicine, Cerrahpasa Medical School, Istanbul University-CerrahpasaDivision of Rheumatology, Department of Medicine, Cerrahpasa Medical School, Istanbul University-CerrahpasaDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum ErlangenInternal Medicine (Rheumatology), Academic HospitalAbstract Background It was our impression that safety outcome trials were getting more frequent, raising ethical issues mainly related to patient autonomy. We and others had also proposed this autonomy would be best served if wording of the informed consents would be in the public domain. Methods Initially two observers and an arbiter tabulated the main aims of randomized controlled trials (RCTs) published in 1990–1991 vs. 2019–2020 as efficacy, safety, or undecided in four mainline medical journals, from the websites. A pragmatic design as well as other salient features was also tabulated. After noting too many trials were categorized as undecided, two additional independent observers and the arbiter did a reassessment. Results In our reassessment of 889 RCTs, 309 in earlier and 580 in the later time period, 828 (93%) were categorized as efficacy and 47 (5%) as a safety trial. We were undecided in 14 (2%) trials. The proportion of safety outcome trials between the two time periods were similar [14/309 (5%) vs. 33/580 (6%)] while RCTs of any category conducted in the critical care settings notably increased in time [12/309 (4%) vs. 52/580 (9%) OR 2.4; 1.3–4.6]. Death was a primary outcome measure in 0/14 among the earlier and 16/33 (49%) among the later safety outcome trials. Stroke in 9 and myocardial infarction in 8 safety outcome trials were additional primary outcome measures in the same group. There were 2 pragmatic trials in the earlier and 93 in the later period. Conclusion Although we did not observe a differential increase among the safety outcome trials of all categories, those in critical care settings had significantly increased in time. So did the safety outcome trials with primary outcome measures like death, myocardial infarction, and stroke as well as randomized controlled trials with a pragmatic design. These raise the issue of autonomy related to how clearly the sought-after safety through designing empirical studies primarily to quantitate harm had been worded to the trial participants in plain language. We maintain this issue cannot be adequately addressed unless the informed consent forms, especially for safety outcome trials, are in the public domain.https://doi.org/10.1186/s13063-025-08732-xRandomized controlled trialsInformed consentStudy aimPrimary outcome measuresNuremberg CodeHelsinki Code |
| spellingShingle | Sinem Nihal Esatoglu Ayse Ozdede Yesim Ozguler Koray Tascilar Hasan Yazici Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents Trials Randomized controlled trials Informed consent Study aim Primary outcome measures Nuremberg Code Helsinki Code |
| title | Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents |
| title_full | Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents |
| title_fullStr | Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents |
| title_full_unstemmed | Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents |
| title_short | Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents |
| title_sort | safety outcome trials in four mainline medical journals 30 years apart a narrative review and the need for the transparency of informed consents |
| topic | Randomized controlled trials Informed consent Study aim Primary outcome measures Nuremberg Code Helsinki Code |
| url | https://doi.org/10.1186/s13063-025-08732-x |
| work_keys_str_mv | AT sinemnihalesatoglu safetyoutcometrialsinfourmainlinemedicaljournals30yearsapartanarrativereviewandtheneedforthetransparencyofinformedconsents AT ayseozdede safetyoutcometrialsinfourmainlinemedicaljournals30yearsapartanarrativereviewandtheneedforthetransparencyofinformedconsents AT yesimozguler safetyoutcometrialsinfourmainlinemedicaljournals30yearsapartanarrativereviewandtheneedforthetransparencyofinformedconsents AT koraytascilar safetyoutcometrialsinfourmainlinemedicaljournals30yearsapartanarrativereviewandtheneedforthetransparencyofinformedconsents AT hasanyazici safetyoutcometrialsinfourmainlinemedicaljournals30yearsapartanarrativereviewandtheneedforthetransparencyofinformedconsents |